Blogs

24 July, 2026

Top Strategies to Avoid Costly FDA Submission Mistakes in 2025

By Vigilare Biopharma March 25, 2025

Read Full Blog
Combination Products

24 July, 2026

Advancing Diversity, Equity, and Inclusion (DEI) in Clinical Research: A Path Toward Equitable Healthcare

By Vigilare Biopharma April 17, 2025

Read Full Blog
Regulatory Affairs

24 July, 2026

Mastering Post-Approval Changes: Transform Regulatory Hurdles into a Competitive Advantage

By Vigilare Biopharma April 29, 2025

Read Full Blog
Clinical Trials

24 July, 2026

Outsourcing Clinical Trials to India: Global Regulation, Ethics, and the Future of Pharmaceutical Research

By Vigilare Biopharma May 12, 2025

Read Full Blog
Pharmacovigilance

24 July, 2026

Vigilare Biopharma Insights: TGA Seeks Feedback to Modernize Clinical Trial & Pharmacovigilance Standards

By Vigilare Biopharma May 20, 2025

Read Full Blog
Pharmacovigilance

24 July, 2026

Why is a good Pharmacovigilance partner important for business?

By Vigilare Biopharma April 10, 2023

Read Full Blog
Quality Compliance

24 July, 2026

The Importance of Vendor Audits: Ensuring Compliance and Quality Across Industries

a"> By Vigilare Biopharma July 29, 2025

Read Full Blog
Regulatory Affairs

23 July, 2026

PRAC June 2025 Meeting Insights: What It Means & How Vigilare Biopharma Can Help

From Vigilare Biopharma: The recent PRAC meeting (2-5 June 2025) underscores the relentless pace of pharmacovigilance evolution.

Read Full Blog
Regulatory Affairs

23 July, 2026

How do pharma companies navigate the complex regulatory landscape and ensure compliance with applicable laws and regulations?

By Vigilare Biopharma April 10, 2023

Read Full Blog